Page 2 of 10 – SEC Filing
| CUSIP No. 50127T109 | 13G | Page 2 of 9 Pages |
| 1. | NAMES OF REPORTING PERSONS Great Point Partners, LLC I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 37-1475292 | |
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | |
| (a) | o | |
| (b) | o | |
| 3. | SEC USE ONLY | |
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION USA | |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 0 |
| 6. | SHARED VOTING POWER 1,638,461 | |
| 7. | SOLE DISPOSITIVE POWER 0 | |
| 8. | SHARED DISPOSITIVE POWER 1,638,461 |
| 9. | AGGREGATE 1,638,461 | |
| 10. | CHECK
| o
|
| 11. | PERCENT 5.92%1 | |
| 12. | TYPE IA | |
| 1 | Based on a total of 27,687,986 shares outstanding, as reported by the Issuer in a Prospectus Supplement filed with the SEC on August 11, 2017. |
Follow Kura Oncology Inc. (NASDAQ:KURA) Follow Kura Oncology Inc. (NASDAQ:KURA)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
